View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 1, 2020

FDA launches new programme to speed-up Covid-19 therapies

The US Food and Drug Administration (FDA) has launched a new programme aimed at accelerating the development of potential treatments for Covid-19 infection.

Under the Coronavirus Treatment Acceleration Program (CTAP), FDA is working to quickly bring therapies to patients.

Furthermore, the agency is supporting research to validate the safety and effectiveness of these Covid-19 treatments.

Read the full article here

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy